Theorem Clinical Research, a US contract research organisation (CRO), has appointed Brian Bollwage to the position of vice president of global regulatory affairs.
Bollwage was previously director of global regulatory science at Bristol-Myers Squibb and executive director and regulatory counsel of global regulatory intelligence at i3 Research.
He is a food and drug law expert and a graduate of Rutgers Law School. He currently serves as an associate professor of food and drug law at Temple University in Philadelphia.
Theorem Clinical Research appoints vp of global regulatory affairs
Brian Bollwage is a food and drug law expert
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Packaging
Cloud labelling and serialisation: the new frontline of traceability in drug delivery
As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence